Connection

Eric Rovner to Male

Back to Details
This is a "connection" page, showing publications Eric Rovner has written about Male.
Eric Rovner
Connection Strength
0.662
Male
  1. Urinary retention after AdVance? Sling: A multi-institutional retrospective study. Neurourol Urodyn. 2021 01; 40(1):515-521.
    View in: PubMed
    Score: 0.040
  2. Persistent Dysuria in a Young Male. Urology. 2021 02; 148:e29-e30.
    View in: PubMed
    Score: 0.040
  3. Shortness of Breath Secondary to a Massive Bladder Diverticulum: A Unique Transvesical Repair. Urology. 2020 08; 142:e1-e3.
    View in: PubMed
    Score: 0.038
  4. Feasibility of a Fully Implanted, Nickel Sized and Shaped Tibial Nerve Stimulator for the Treatment of Overactive Bladder Syndrome with Urgency Urinary Incontinence. J Urol. 2019 05; 201(5):967-972.
    View in: PubMed
    Score: 0.036
  5. A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology. Contemp Clin Trials. 2018 07; 70:83-87.
    View in: PubMed
    Score: 0.033
  6. Long-Term Efficacy and Safety of OnabotulinumtoxinA in Patients with Neurogenic Detrusor Overactivity Who Completed 4 Years of Treatment. J Urol. 2016 Sep; 196(3):801-8.
    View in: PubMed
    Score: 0.029
  7. New treatments for incontinence. Adv Chronic Kidney Dis. 2015 Jul; 22(4):279-88.
    View in: PubMed
    Score: 0.027
  8. OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2013 Nov; 32(8):1109-15.
    View in: PubMed
    Score: 0.023
  9. Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder. Neurourol Urodyn. 2011 Apr; 30(4):556-62.
    View in: PubMed
    Score: 0.020
  10. Effect of A 7-F transurethral catheter on abdominal leak point pressure measurement in men with post-prostatectomy incontinence. Urology. 2011 May; 77(5):1188-93.
    View in: PubMed
    Score: 0.020
  11. Effect of tolterodine extended release with or without tamsulosin on measures of urgency and patient reported outcomes in men with lower urinary tract symptoms. J Urol. 2008 Sep; 180(3):1034-41.
    View in: PubMed
    Score: 0.017
  12. Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology. 2008 Sep; 72(3):488-93.
    View in: PubMed
    Score: 0.017
  13. Sexual health in adult men with spina bifida. ScientificWorldJournal. 2007 Sep 01; 7:1466-9.
    View in: PubMed
    Score: 0.016
  14. Complications of prostate cancer treatment: spectrum of imaging findings. Radiographics. 2004 Oct; 24 Suppl 1:S181-94.
    View in: PubMed
    Score: 0.013
  15. Trospium chloride in the management of overactive bladder. Drugs. 2004; 64(21):2433-46.
    View in: PubMed
    Score: 0.012
  16. Definition and epidemiology of overactive bladder. Urology. 2002 Nov; 60(5 Suppl 1):7-12; discussion 12.
    View in: PubMed
    Score: 0.011
  17. Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. Eur Urol. 2002 Jan; 41(1):6-14.
    View in: PubMed
    Score: 0.011
  18. Significance of hematuria in patients with interstitial cystitis: review of radiographic and endoscopic findings. Urology. 2001 Feb; 57(2):262-5.
    View in: PubMed
    Score: 0.010
  19. Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group. Urology. 2000 Dec 20; 56(6):940-5.
    View in: PubMed
    Score: 0.010
  20. Preparation and Utilization of Freshly Isolated Human Detrusor Smooth Muscle Cells for Characterization of 9-Phenanthrol-Sensitive Cation Currents. J Vis Exp. 2020 01 31; (155).
    View in: PubMed
    Score: 0.009
  21. Organ-sparing surgery for bilateral leydig cell tumor of the testis. Urology. 1999 Oct; 54(4):744.
    View in: PubMed
    Score: 0.009
  22. Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE). Adv Ther. 2019 08; 36(8):1906-1921.
    View in: PubMed
    Score: 0.009
  23. The overactive bladder: an overview for primary care health providers. Int J Fertil Womens Med. 1999 Mar-Apr; 44(2):56-66.
    View in: PubMed
    Score: 0.009
  24. Nongenomic modulation of the large conductance voltage- and Ca2+-activated K+ channels by estrogen: A novel regulatory mechanism in human detrusor smooth muscle. Physiol Rep. 2017 Jul; 5(14).
    View in: PubMed
    Score: 0.008
  25. Transurethral biopsy of the prostate for persistently elevated or increasing prostate specific antigen following multiple negative transrectal biopsies. J Urol. 1997 Jul; 158(1):138-41; discussion 141-2.
    View in: PubMed
    Score: 0.008
  26. Regulation of transient receptor potential melastatin 4 channel by sarcoplasmic reticulum inositol trisphosphate receptors: Role in human detrusor smooth muscle function. Channels (Austin). 2017 Sep 03; 11(5):459-466.
    View in: PubMed
    Score: 0.008
  27. A three dimensional nerve map of human bladder trigone. Neurourol Urodyn. 2017 04; 36(4):1015-1019.
    View in: PubMed
    Score: 0.007
  28. BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle function. Am J Physiol Renal Physiol. 2016 05 15; 310(10):F994-9.
    View in: PubMed
    Score: 0.007
  29. Novel regulatory mechanism in human urinary bladder: central role of transient receptor potential melastatin 4 channels in detrusor smooth muscle function. Am J Physiol Cell Physiol. 2016 Apr 01; 310(7):C600-11.
    View in: PubMed
    Score: 0.007
  30. Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity. Neurourol Urodyn. 2016 06; 35(5):595-600.
    View in: PubMed
    Score: 0.007
  31. Functional link between muscarinic receptors and large-conductance Ca2+ -activated K+ channels in freshly isolated human detrusor smooth muscle cells. Pflugers Arch. 2015 Apr; 467(4):665-75.
    View in: PubMed
    Score: 0.006
  32. BRL37344, a ?3-adrenergic receptor agonist, decreases nerve-evoked contractions in human detrusor smooth muscle isolated strips: role of BK channels. Urology. 2013 Sep; 82(3):744.e1-7.
    View in: PubMed
    Score: 0.006
  33. Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and Ca(2+)-activated K(+) channels. PLoS One. 2013; 8(7):e68052.
    View in: PubMed
    Score: 0.006
  34. Single-channel biophysical and pharmacological characterizations of native human large-conductance calcium-activated potassium channels in freshly isolated detrusor smooth muscle cells. Pflugers Arch. 2013 Jul; 465(7):965-75.
    View in: PubMed
    Score: 0.006
  35. SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscle. Am J Physiol Regul Integr Comp Physiol. 2013 Jan 15; 304(2):R155-63.
    View in: PubMed
    Score: 0.006
  36. Selective inhibition of phosphodiesterase 1 relaxes urinary bladder smooth muscle: role for ryanodine receptor-mediated BK channel activation. Am J Physiol Cell Physiol. 2012 Nov 15; 303(10):C1079-89.
    View in: PubMed
    Score: 0.006
  37. Constitutively active phosphodiesterase activity regulates urinary bladder smooth muscle function: critical role of KCa1.1 channel. Am J Physiol Renal Physiol. 2012 Nov 01; 303(9):F1300-6.
    View in: PubMed
    Score: 0.006
  38. Investigation of a Ca2+ channel a2d ligand for the treatment of interstitial cystitis: results of a randomized, double-blind, placebo controlled phase II trial. J Urol. 2012 Sep; 188(3):817-23.
    View in: PubMed
    Score: 0.006
  39. SK but not IK channels regulate human detrusor smooth muscle spontaneous and nerve-evoked contractions. Am J Physiol Renal Physiol. 2012 Aug 15; 303(4):F559-68.
    View in: PubMed
    Score: 0.006
  40. Expression and function of K(V)2-containing channels in human urinary bladder smooth muscle. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1599-608.
    View in: PubMed
    Score: 0.005
  41. Suppression of human detrusor smooth muscle excitability and contractility via pharmacological activation of large conductance Ca2+-activated K+ channels. Am J Physiol Cell Physiol. 2012 Jun 01; 302(11):C1632-41.
    View in: PubMed
    Score: 0.005
  42. Large-conductance voltage- and Ca2+-activated K+ channels regulate human detrusor smooth muscle function. Am J Physiol Cell Physiol. 2011 Oct; 301(4):C903-12.
    View in: PubMed
    Score: 0.005
  43. Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials. Drugs Aging. 2011 Feb 01; 28(2):151-60.
    View in: PubMed
    Score: 0.005
  44. Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged = 75 years) with overactive bladder syndrome. BJU Int. 2011 Feb; 107(4):612-20.
    View in: PubMed
    Score: 0.005
  45. Long-term durability of percutaneous tibial nerve stimulation for the treatment of overactive bladder. J Urol. 2010 Jan; 183(1):234-40.
    View in: PubMed
    Score: 0.005
  46. Patient-reported reasons for discontinuing overactive bladder medication. BJU Int. 2010 May; 105(9):1276-82.
    View in: PubMed
    Score: 0.005
  47. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity. BJU Int. 2010 May; 105(9):1268-75.
    View in: PubMed
    Score: 0.005
  48. Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. J Urol. 2009 Sep; 182(3):1055-61.
    View in: PubMed
    Score: 0.005
  49. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008 May; 179(5):1850-6.
    View in: PubMed
    Score: 0.004
  50. Fesoterodine dose response in subjects with overactive bladder syndrome. Urology. 2008 May; 71(5):839-43.
    View in: PubMed
    Score: 0.004
  51. Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol. 2007 Feb; 177(2):556-60.
    View in: PubMed
    Score: 0.004
  52. Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial. JAMA. 2006 Nov 15; 296(19):2319-28.
    View in: PubMed
    Score: 0.004
  53. Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia. Urology. 2006 Aug; 68(2):328-32.
    View in: PubMed
    Score: 0.004
  54. Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence. BJU Int. 2006 May; 97(5):1003-6.
    View in: PubMed
    Score: 0.004
  55. Nighttime dosing with tolterodine reduces overactive bladder-related nocturnal micturitions in patients with overactive bladder and nocturia. Urology. 2006 Apr; 67(4):731-6; discussion 736.
    View in: PubMed
    Score: 0.004
  56. The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue--the BSW. Value Health. 2005 Nov-Dec; 8 Suppl 1:S25-34.
    View in: PubMed
    Score: 0.003
  57. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005 Jan; 173(1):93-7.
    View in: PubMed
    Score: 0.003
  58. Is urine methylhistamine a useful marker for interstitial cystitis? J Urol. 2004 Dec; 172(6 Pt 1):2256-60.
    View in: PubMed
    Score: 0.003
  59. Urologic complications of nonurologic medications. Urol Clin North Am. 2003 Feb; 30(1):123-31.
    View in: PubMed
    Score: 0.003
  60. Renal vein thrombosis after martial arts trauma. J Trauma. 2001 Jan; 50(1):144-5.
    View in: PubMed
    Score: 0.003
  61. Injected periurethral collagen for postprostatectomy urinary incontinence: MR and CT appearance. Abdom Imaging. 2000 Nov-Dec; 25(6):658-62.
    View in: PubMed
    Score: 0.002
  62. Continence mechanism based on a modified ileocecal valve. Tech Urol. 2000 Sep; 6(3):167-71.
    View in: PubMed
    Score: 0.002
  63. Erectile function and quality of life after interstitial radiation therapy for prostate cancer. Int J Impot Res. 2000 Sep; 12 Suppl 3:S18-24.
    View in: PubMed
    Score: 0.002
  64. Artificial urinary sphincter for post-prostatectomy incontinence: impact of prior collagen injection on cost and clinical outcome. J Urol. 2000 Jan; 163(1):87-90.
    View in: PubMed
    Score: 0.002
  65. Strategy for repeat biopsy of patients with prostatic intraepithelial neoplasia detected by prostate needle biopsy. J Urol. 1996 Jan; 155(1):228-31.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.